Gut Microbial Profile Changes in Patients with Gallbladder Stones after UDCA/CDCA Treatment

Background: Ursodeoxycholic acid (UDCA) and chenodeoxycholic acid (CDCA) are used to treat patients with asymptomatic or mildly symptomatic gallstone disease. This study was conducted to evaluate the efficacy of gallbladder (GB) stone dissolution by UDCA/CDCA and the impact of treatment on gut micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jungnam, Lee, Sohee, Kim, Hanul, Bae, Jaewoong, Park, Jin-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045859/
https://www.ncbi.nlm.nih.gov/pubmed/36979756
http://dx.doi.org/10.3390/biomedicines11030777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045859/
https://www.ncbi.nlm.nih.gov/pubmed/36979756
http://dx.doi.org/10.3390/biomedicines11030777

Ejemplares similares